Position
Entropy Technologies, LP in Sarepta Therapeutics, Inc.
Back to the book · All holders of SRPT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $4.72K$21.52 → $21.76
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 35.7K | $767.9K | — | — | — | 0.0% |
| Q1 2026 | 19.7K | $428.1K | $21.76 | $4.72K | −$344.5K | 0.0% |